Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,435 public trials 3,300 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Completed

Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer

NCT00393068

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +7 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Integrated Community Oncology Network Jacksonville, Florida, United States
  • Northeast Georgia Medical Center Gainesville, Georgia, United States
  • Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States
View Trial Details
Completed

A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer

NCT01896531

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations
  • Univ of Calif, Los Angeles; Hematology/Oncology Los Angeles, California, United States
  • Massachusetts General Hospital;Oncology Boston, Massachusetts, United States
  • University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
  • Institut Gustave Roussy; Departement Oncologie Medicale Villejuif, France
View all 34 locations
View Trial Details
Completed

A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma

NCT02178358

Conditions
Adenocarcinoma, Bone Diseases, Bone Diseases, Developmental, +16 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bengbu, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changchun, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China
View all 16 locations
View Trial Details
Completed

Chimeric Antigen Receptor T Cells Targeting Glypican-3

NCT03884751

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
  • The 81st Hospital of Chinese PLA Nanjing, Jiangsu, China
  • Renji Hospital Shang Hai Jiaotong Unversity of Medicine Shanghai, Shanghai Municipality, China
View Trial Details
Completed

Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor

NCT03985072

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Carcinoma, +38 more
Locations
  • Fundacion Arturo Lopez Perez Santiago, Santiago Metropolitan, Chile
  • Centro de Cancer de Nuestra Senora de la Esperanza, Red de Salud UC CHRISTUS Santiago, Santiago Metropolitan, Chile
  • Instituto Nacional del Cáncer (INCANCER) Santiago, Santiago Metropolitan, Chile
  • Centro de Investigaciones Clinicas Vina del Mar Viña del Mar, V Region de Valparaiso, Chile
View Trial Details

Related conditions